{
  "kind": "framework",
  "value": "biological-mechanism-mapping",
  "collectionKey": "slides:framework:biological-mechanism-mapping:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 2,
  "page": 1,
  "pageSize": 24,
  "pageCount": 1,
  "rows": [
    {
      "docId": "019de072-f0cb-7745-907c-f9e6b87d2817",
      "docSlug": "e5afd111c5ca3d26ccce5d5b91b81d60",
      "documentTitle": "BioNTech | Investor Day Presentation Deck | 156 slides",
      "authorId": "biontech",
      "authorName": "BioNTech",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "other",
      "function": "present_framework",
      "notes": "The slide maps biological interactions (APC, T cell, Tumor cells, etc.) to five specific therapeutic modalities (mRNA vaccines, cell therapies, immunomodulators, etc.).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "Mapping of biological cell interactions to therapeutic modalities",
      "slideHref": "/slides/019de072-f0cb-7745-907c-f9e6b87d2817/16",
      "deckHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817",
      "deckAnchorHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817#slide-16",
      "loopMatches": [
        {
          "to": 20,
          "from": 7,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "ac68e7db-aea6-4d80-8edc-ba3ff205e332",
          "evidence": "The presentation opens with a clear problem statement and builds a logic chain to introduce BioNTech's solution",
          "position": 0,
          "objective": "Explain the role of the immune system in human diseases and BioNTech's solution",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.7,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        },
        {
          "to": 30,
          "from": 10,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "5abee4e9-bad9-4c98-8e0f-028711be24f9",
          "evidence": "The presentation uses the Golden Circle framework to explain the 'why', 'what', and 'how' of BioNTech's mRNA technology",
          "position": 1,
          "objective": "Explain the 'why', 'what', and 'how' of BioNTech's mRNA technology",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 10,
          "beatId": "97149298-ce68-4bbe-9759-62673752d664",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution Overview",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The presentation then provides an overview of BioNTech's solution, including its innovation pillars and mRNA technology",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de072-f0cb-7745-907c-f9e6b87d2817",
      "docSlug": "e5afd111c5ca3d26ccce5d5b91b81d60",
      "documentTitle": "BioNTech | Investor Day Presentation Deck | 156 slides",
      "authorId": "biontech",
      "authorName": "BioNTech",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-06-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 92,
      "slideType": "other",
      "function": "present_framework",
      "notes": "The slide maps biological interactions (APC, T cell, Tumor cells) to numbered therapeutic interventions.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "Mapping of biological cell interactions to therapeutic intervention categories",
      "slideHref": "/slides/019de072-f0cb-7745-907c-f9e6b87d2817/92",
      "deckHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817",
      "deckAnchorHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817#slide-92",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 120,
          "from": 91,
          "beatId": "bf198718-eb7f-470f-aca0-0f710fbb4f37",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Product Pipeline",
          "beatSlug": "sequoia-pitch-product",
          "evidence": "The presentation showcases BioNTech's product pipeline, including its oncology and infectious disease programs",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}